AbbVie | ABBV - 流動負債

株価
208.84
毎日の変更
-6.14 -2.86%
毎月
-10.70%
毎年
3.57%
Q2 予測
202.55




流動負債 変化する 日付
AbbVie USD 43.29B 3.9B 2025-12
Abbott USD 16.5B 1.91B 2025-12
ALKERMES USD 543.44M 69.08M 2025-12
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Coherus Biosciences USD 140.39M 231.91M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
J&J USD 54.13B 3.26B 2025-12
Medtronic USD 9.5B 440M 2025-12
Merck USD 28.63B 2.59B 2025-09
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
UCB EUR 4.4B 470M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
United Therapeutics USD 560.6M 14.3M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Zoetis USD 2.24B 428M 2025-12